Combination Immunotherapy with Cytotoxic T-Lymphocyte–Associated Antigen-4 and Programmed Death Protein-1 Inhibitors Prevents Postoperative Breast Tumor Recurrence and MetastasisTing Sun, Huadan Xue, Zhengyu Jin et al.|Molecular Cancer Therapeutics|2019Cited by 25